[1]李玉红,马凌葵,武桂云.血清ICAM-1、SCUBE-1、DCN水平与视网膜静脉阻塞患者血管内皮功能及预后相关性研究[J].陕西医学杂志,2025,54(2):258-262.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.024]
　LI Yuhong,MA Lingkui,WU Guiyun.Correlation between serum ICAM-1,SCUBE-1 and DCN levels and vascular endothelial function and prognosis in patients with retinal vein occlusion[J].,2025,54(2):258-262.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.024]
点击复制

血清ICAM-1、SCUBE-1、DCN水平与视网膜静脉阻塞患者血管内皮功能及预后相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年2期
页码:
258-262
栏目:
临床检验
出版日期:
2025-02-05

文章信息/Info

Title:
Correlation between serum ICAM-1,SCUBE-1 and DCN levels and vascular endothelial function and prognosis in patients with retinal vein occlusion
作者:
李玉红; 马凌葵; 武桂云
(湖北省天门市第一人民医院眼科,湖北 天门 431700)
Author(s):
LI Yuhong; MA Lingkui; WU Guiyun
(Department of Ophthalmology,the First People's Hospital of Tianmen in Hubei Province,Tianmen 431700,China)
关键词:
视网膜静脉阻塞;  细胞间黏附分子-1;  信号肽-CUB-表皮生长因子结构域包含蛋白1;  核心蛋白多糖;  血管内皮功能;  预后
Keywords:
Retinal vein occlusion;  ICAM-1;  SCUBE-1;  DCN;  Vascular endothelial function;  Prognosis
分类号:
R 774.1
DOI:
DOI:10.3969/j.issn.1000-7377.2025.02.024
文献标志码:
A
摘要:
目的:探究血清细胞间黏附分子-1(ICAM-1)、信号肽-CUB-表皮生长因子结构域包含蛋白1(SCUBE-1)、核心蛋白多糖(DCN)水平与视网膜静脉阻塞(RVO)患者血管内皮功能及预后的相关性。方法:选取RVO患者58例(研究组)和同期体检健康者60例(对照组)。比较两组血清ICAM-1、SCUBE-1、DCN水平和血管内皮功能指标。采用Pearson法分析血清ICAM-1、SCUBE-1、DCN水平与患者血管内皮功能的相关性。根据RVO患者治疗后恢复情况将患者分为预后良好组(21例)和预后不良组(37例)。分析RVO患者预后的影响因素采用多因素Logistic回归。血清ICAM-1、SCUBE-1、DCN对RVO患者预后不良的预测价值通过绘制受试者工作特征(ROC)曲线进行分析。结果:研究组血清ICAM-1、SCUBE-1、DCN水平高于对照组(均P<0.05)。研究组反应性充血指数、一氧化氮水平低于对照组,血管内皮生长因子水平高于对照组(均P<0.05)。血清ICAM-1、SCUBE-1、DCN水平与反应性充血指数及一氧化氮呈负相关,与血管内皮生长因子呈正相关(均P<0.05)。预后良好组血清ICAM-1、SCUBE-1、DCN水平低于预后不良组(均P<0.05)。预后不良组患者合并高血压、视网膜静脉总干部位阻塞的比例高于预后良好组(均P<0.05)。血清ICAM-1、SCUBE-1、DCN、合并高血压、视网膜静脉阻塞部位为RVO患者预后的影响因素(均P<0.05)。血清ICAM-1、SCUBE-1、DCN以及三者联合预测RVO患者预后不良的曲线下面积(AUC)分别为0.804、0.793、0.802、0.933,且三者联合预测的AUC更高(均P<0.05)。结论:RVO患者血清ICAM-1、SCUBE-1、DCN水平升高,与血管内皮功能和预后有关,且三者联合对患者预后具有一定预测价值。
Abstract:
Objective:To explore the correlation between serum levels of ICAM-1,SCUBE-1 and DCN and vascular endothelial function and prognosis in patients with retinal vein occlusion(RVO).Methods:A total of 58 RVO patients(study group)and 60 healthy individuals(control group)were selected.Serum levels of ICAM-1,SCUBE-1 and DCN,as well as vascular endothelial function indicators,were compared between the two groups.Pearson's correlation analysis was used to assess the correlation between serum levels of ICAM-1,SCUBE-1 and DCN and patients' vascular endothelial function.RVO patients were divided into a good prognosis group(21 cases)and a poor prognosis group(37 cases)based on their recovery after treatment.Multifactorial logistic regression analysis was conducted to identify factors affecting the prognosis of RVO patients.ROC curves were plotted to analyze the predictive value of serum ICAM-1,SCUBE-1 and DCN for poor prognosis in RVO patients.Results:Serum levels of ICAM-1,SCUBE-1 and DCN in the study group were higher than those in the control group(all P<0.05).The study group had lower reactive hyperemia index and nitric oxide levels,and higher vascular endothelial growth factor levels compared to the control group(all P<0.05).Serum levels of ICAM-1,SCUBE-1 and DCN were negatively correlated with reactive hyperemia index and nitric oxide,and positively correlated with vascular endothelial growth factor(all P<0.05).The good prognosis group had lower serum levels of ICAM-1,SCUBE-1 and DCN than the poor prognosis group(all P<0.05).The poor prognosis group had a higher proportion of patients with hypertension and central retinal vein obstruction than the good prognosis group(all P<0.05).Serum ICAM-1,SCUBE-1,DCN,comorbidity of hypertension,and the site of retinal vein obstruction were identified as factors affecting the prognosis of RVO patients(all P<0.05).The AUC for predicting poor prognosis in RVO patients for serum ICAM-1,SCUBE-1,DCN and their combination were 0.804,0.793,0.802 and 0.933,respectively,with the combined prediction having a higher AUC(all P<0.05).Conclusion:Elevated serum levels of ICAM-1,SCUBE-1,and DCN in RVO patients are associated with vascular endothelial function and prognosis,and their combined use has predictive value for patient prognosis.

参考文献/References:

[1] 张乐,谭晓丹,沈志华,等.和血明目片治疗糖尿病视网膜病变和视网膜静脉阻塞的系统评价及Meta分析[J].中国实验方剂学杂志,2023,29(18):109-116.
[2] 张分队,陆慧琴,武炳慧,等.光学相干断层扫描血管成像在观察视网膜静脉阻塞患者黄斑血流变化中的临床应用[J].陕西医学杂志,2021,50(1):65-67.
[3] 陆耀楠,庞燕华.视网膜静脉阻塞的治疗现状和进展[J].医学信息,2023,36(14):178-182.
[4] 刚怡.基于Th1/Th2免疫平衡探讨血栓通胶囊对视网膜静脉阻塞的疗效及机制[J].陕西中医,2022,43(7):906-909.
[5] 彭金英,赵桂玲.影响视网膜中央静脉阻塞预后的相关因素研究现状[J].国际眼科杂志,2022,22(7):1127-1132.
[6] 王利军,王建平,牛延良,等.血清sICAM-1水平及ICAM-1基因K469E多态性与脑小血管病关系研究[J].中风与神经疾病杂志,2019,36(10):902-905.
[7] 丁瑞东,刘文强,李聪,等.血清MCP-1及ICAM-1对早产儿视网膜病变的早期预测价值[J].眼科新进展,2023,43(8):633-637.
[8] 林晓伟,邓明尧,吉晓理,等.血清SCUBE1、Endocan水平与急性ST段抬高型心肌梗死患者PCI术后冠状动脉无复流的关系[J].中国动脉硬化杂志,2023,31(1):56-62.
[9] 梁文涛,刘畅,万修华,等.2型糖尿病并发视网膜病变患者血清皮质醇、肌生成抑制素、 SCUBE-1水平变化及临床意义[J].国际检验医学杂志,2023,44(14):1687-1692.
[10] 马建洲,孙红彬,马丽娜.血清和房水核心蛋白多糖水平与糖尿病视网膜病变的关系[J].东南大学学报(医学版),2023,42(4):584-589.
[11] 邵毅,张雨晴,周琼.视网膜静脉阻塞诊疗规范—2019年欧洲视网膜专家协会指南解读[J].眼科新进展,2020,40(6):501-504.
[12] 刘志强,李亚坤,白玫,等.基于VEGF途径探究丹参素对大鼠视网膜静脉阻塞及对视网膜功能的改善作用机制[J].中国比较医学杂志,2023,33(5):52-60.
[13] 高桂芬.视网膜静脉阻塞患者视力预后相关因素分析[J].世界复合医学,2019,5(3):95-97.
[14] 王少龙,孙艳,侯宁,等.视网膜分支静脉阻塞抗VEGF治疗患者脉络膜血管指数的变化及其临床意义[J].山东医药,2022,62(28):34-37.
[15] 蒋文荣,夏鹰,金虎,等.颅内动脉瘤患者血清MCP-1、ICAM-1、NF-κB水平变化及介入手术后阿托伐他汀的治疗效果[J].山东医药,2023,63(13):63-65.
[16] 李开元,艾明.血清ICAM-1、VEGF水平与老年糖尿病视网膜病变患者微血管损伤的相关性研究[J].中华保健医学杂志,2019,21(1):47-49.
[17] 陈梅,才让,祁蕙燕,等.护网明目汤对糖尿病视网膜病变患者血流动力学及血清ICAM-1、ET-1变化的临床观察[J].北京中医药大学学报,2018,41(7):599-604.
[18] 梁保,金志刚,程愿玲,等.血清表皮生长因子结构域包含蛋白1与急性心肌梗死患者血栓负荷及预后的关系[J].中华老年心脑血管病杂志,2023,25(8):818-822.
[19] 何川鄂,饶毅峰,宋志霞,等.血清SCUBE-1及EndoCan水平与血液透析患者动静脉内瘘血栓形成的关系[J].西部医学,2023,35(2):227-231.
[20] 吴凡,王千秋.核心蛋白聚糖生物学功能研究进展[J].医学综述,2017,23(2):249-253.
[21] 姜琪,邓丽娟,张艳,等.特发性间质性肺炎急性加重期患者血清核心蛋白多糖、血管生成素-2的表达及临床意义[J].国际检验医学杂志,2021,42(8):916-920.
[22] 叶芬,於翔,黄振平.角膜新生血管发生机制及治疗研究新进展[J].国际眼科杂志,2013,13(1):82-84.
[23] 李坤,吴艳平,冯俊丽.血清AQP4、DCN、Apelin水平对早产儿视网膜病变诊断及病理分期的评估价值[J].国际检验医学杂志,2024,45(14):1740-1744.
[24] 罗燕,谢良地,邱东飚.原发性高血压合并2型糖尿病患者的血管内皮功能[J].中华高血压杂志,2021,29(2):141-148.
[25] 马葛洋.甲泼尼龙片联合康柏西普治疗视网膜静脉阻塞患者的临床研究[J].淮海医药,2024,42(1):72-75.

相似文献/References:

[1]张分队,陆慧琴,武炳慧,等.光学相干断层扫描血管成像在观察视网膜静脉阻塞患者黄斑血流变化中的临床应用[J].陕西医学杂志,2021,50(1):65.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.017]

备注/Memo

备注/Memo:
[基金项目]湖北省卫生健康科研立项课题(WJ2021F101)
更新日期/Last Update: 2025-02-04